Precancerous Lesion
6
1
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Molecular Markers in Cancers and Precancers (MOCA)
HPV DNA Self-sampling in a General Practitioner's Office.
Associations Among Serum and Gastric Juice Bile Acid Profile, Bile Acid-microbiota Cross-talk in Stomach and the Development of Gastric Cancer
Study on the Diagnostic Value of Multi-omics Combined Detection for Precancerous Lesions of CRC
Nasal Endoscopic Screening and Risk Assessment for Early Gastric Cancer
The Research of Constructing a Risk Assessment Model for Gastric Cancer Based on Machine Learning